About Us Strategy & Mission Our Values Our People Our Board Our Collaborations Contact Our Programmes Overview Pipeline C. difficile Infection Enterobacteriaceae ESKAPE Programme Clinical Trials Stewardship Compassionate Use Our Science Discuva Platform Publications Investors Investor Centre Press Releases Financial Reports & Filings Email Alerts Events & Presentations Share Price Data Analyst Coverage Corporate Governance Shareholder Meetings Careers
Efficacy Of SMT19969 And SMT21829 In A Hamster Model Of Clostridium Difficile Associated Disease (CDAD) Efficacy Of SMT19969 And SMT21829 In A Hamster Model Of Clostridium Difficile Associated Disease (CDAD) September 10, 2011 By CKD Digital
Efficacy Of SMT19969 And SMT21829 In A Hamster Model Of Clostridium Difficile Associated Disease (CDAD)
Efficacy Of SMT19969 And SMT21829 In A Hamster Model Of Clostridium Difficile Associated Disease (CDAD) September 10, 2011 By CKD Digital
